Canada's Firefly Neuroscience has completed a listing on the Nasdaq via a $45 million reverse merger with IT group WaveDancer, opening up new financing routes for its artificial intelligenc
An FDA-approved digital therapeutic (DTx) that can be used to help people living with major depressive disorder (MDD) has been launched in the US and is available in mobile app stores.
A group of healthcare industry veterans have launched a new investment fund – called Create Health Ventures – with $21 million in the pot to support early-stage companies with tech that can
Otsuka has teamed up with one of the innovation arms of the NHS to explore how a digital therapeutic (DTx) for major depressive disorder (MDD) could be deployed within the health service.
Linus Health, a specialist in digital detection of dementia, has expanded its focus to include the treatment of patients with the acquisition of Together Senior Health.